Bnp-Paribas-Financial-Markets

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
4,665
Total Value
30687523338
Accession Number
0001166588-25-000031
Form Type
13F-HR
Manager Name
Bnp-Paribas-Financial-Markets
Data Enrichment
85% identified
3,953 identified712 unidentified

Holdings

4,665 positions • $30.7B total value
Manager:
Search and click to pin securities to the top
Page 205 of 227
Inozyme Pharma, Inc.
Shares:3.7K
Value:$3.3K
% of Portfolio:0.0% ($3.3K/$30.7B)
bluebird bio, Inc.
Shares:679
Value:$3.3K
% of Portfolio:0.0% ($3.3K/$30.7B)
126633205
Shares:44
Value:$3.3K
% of Portfolio:0.0% ($3.3K/$30.7B)
Black Diamond Therapeutics, Inc.
Shares:2.1K
Value:$3.3K
% of Portfolio:0.0% ($3.3K/$30.7B)
Werewolf Therapeutics, Inc.
Shares:3.4K
Value:$3.3K
% of Portfolio:0.0% ($3.3K/$30.7B)
Maiden Holdings, Ltd.
Shares:5.6K
Value:$3.2K
% of Portfolio:0.0% ($3.2K/$30.7B)
RED ROBIN GOURMET BURGERS INC
Shares:892
Value:$3.2K
% of Portfolio:0.0% ($3.2K/$30.7B)
46435GAA0
Shares:129
Value:$3.1K
% of Portfolio:0.0% ($3.1K/$30.7B)
Mural Oncology plc
Shares:2.4K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
Golden Matrix Group, Inc.
Shares:1.5K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
RENOVARO INC.
Shares:5.5K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
Verde Clean Fuels, Inc.
Shares:891
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
Nautilus Biotechnology, Inc.
Shares:3.5K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
Corvus Pharmaceuticals, Inc.
Shares:933
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
Actinium Pharmaceuticals, Inc.
Shares:1.8K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$30.7B)
Sound Group Inc.
Shares:1.3K
Value:$2.9K
% of Portfolio:0.0% ($2.9K/$30.7B)
921946794
Shares:40
Value:$2.9K
% of Portfolio:0.0% ($2.9K/$30.7B)
88145X108
Shares:347
Value:$2.9K
% of Portfolio:0.0% ($2.9K/$30.7B)
Akoya Biosciences, Inc.
Shares:2.1K
Value:$2.9K
% of Portfolio:0.0% ($2.9K/$30.7B)
Ispire Technology Inc.
Shares:1.1K
Value:$2.9K
% of Portfolio:0.0% ($2.9K/$30.7B)